A recent systematic review and meta-analysis suggests that more exposure to fluoride may be linked to lower intelligence ...

KeyBanc Capital Markets sustained its Overweight rating for Meta Platforms Inc. (NASDAQ: NASDAQ:META), now trading at $676.49 ...

Meta's top AI scientist Yann LeCun said there is a 'major misunderstanding' about how billions in AI investment will be used.

Rosenblatt Securities adjusted their outlook on Meta Platforms Inc. (NASDAQ: NASDAQ:META), increasing the price target to ...

Meta's substantial investment in AI infrastructure, particularly in advertising, is expected to continue driving revenue growth. Read more about META stock here.

Glutamatergic medications are linked to significant symptom improvement in obsessive-compulsive and related disorders, a new ...

Prescribing physical activity to older adults reduces risk factors for chronic disease and improves functional independence, ...

A network meta-analysis of 73 trials comparing the effectiveness of flu antivirals suggests that only baloxavir (Xofluza) may ...

Meta and Tesla rally after-hours, while Microsoft slides. Stock futures edge higher—will the gains hold? Full market analysis ...